Key facts
- E3A Healthcare’s last known valuation is $80.0M.
- It has raised $12.0M; the latest was Later Stage VC ($15.0M) in May 2025.
- Notable investors include SEEDS Capital, Hong Kong Science & Technology Parks, Watten Investments, BLOCK71, CR Enterprise — 22 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for E3A Healthcare
- ·The full record, as it builds
Funding rounds
No funding rounds for E3A Healthcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About E3A Healthcare
Developer of artificial intelligence (AI)-driven non-invasive medical devices designed to support pregnancy, newborn care, and women's chronic health management, serving healthcare providers and patients. The company offers a data-driven platform including passive fetal monitoring and labor prediction, home-based neonatal jaundice monitoring with phototherapy, and neuromodulation therapy for endometriosis and adenomyosis, enabling clinicians and families to monitor and manage care outside hospital settings with clinical oversight.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2019
- Employees
- 60
- Website
- e3ahealth.com/
- Ownership
- Privately Held (backing)
E3A Healthcare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in E3A Healthcare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on E3A Healthcare in its N-PORT filings yet. We sweep new filings monthly.